Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)

SHA:688076 Revenue

Jiangsu Sinopep-Allsino Biopharmaceutical had revenue of 565.60M CNY in the quarter ending March 31, 2025, with 58.96% growth. This brings the company's revenue in the last twelve months to 1.83B, up 55.29% year-over-year. In the year 2024, Jiangsu Sinopep-Allsino Biopharmaceutical had annual revenue of 1.62B with 57.21% growth.

• Revenue (ttm): 1.83B
• Revenue Growth: +55.29%
• P/S Ratio: 6.15
• Revenue / Employee: 904.63K
• Employees: 1,545
• Market Cap: 11.28B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.62B	591.25M	57.21%
Dec 31, 2023	1.03B	382.26M	58.69%
Dec 31, 2022	651.29M	7.42M	1.15%
Dec 31, 2021	643.87M	77.00M	13.58%
Dec 31, 2020	566.87M	195.34M	52.58%